无功能G1/G2胰腺神经内分泌肿瘤复发风险影像-病理整合模型
本研究为多中心回顾性队列研究,纳入中国三家三级中心接受根治性切除的无功能G1/G2胰腺神经内分泌肿瘤患者。利用Fine-Gray竞争风险回归识别复发相关因素,基于六项术前CT征象构建影像侵袭指数,并与临床病理变量整合建立预测模型。结果显示整合模型在训练集和验证集中均改善了24个月和36个月的复发预测效能。
要点
- 影像侵袭指数由六项术前CT征象加权得出,提示影像特征可辅助复发风险分层。
- 肿瘤大小、G2分级、神经周围侵犯和影像侵袭指数是复发的独立预测因子。
- 整合模型将患者分为不同风险组,可为个体化随访策略提供参考。
核心结论
- 整合影像侵袭指数与临床病理因素的模型可能改善无功能G1/G2胰腺神经内分泌肿瘤术后的复发预测,并支持个体化风险分层。
- 在训练集和验证集中,纳入影像指数后模型对24个月和36个月复发的预测效能均有提升。
研究设计与样本
- 多中心回顾性队列研究,纳入中国三家三级中心接受根治性切除的无功能G1/G2胰腺神经内分泌肿瘤患者。
- 训练集310例,验证集70例。
- 采用Fine-Gray竞争风险回归识别复发相关因素。
- 影像侵袭指数由六项常规术前CT征象加权得出。
关键影像表现/征象
- 影像侵袭指数源自六项常规术前CT征象,原文未逐一列举具体征象名称及各自权重。
诊断标准与关键数值
- 肿瘤大小:sHR=1.111,95%CI 1.013-1.218,p=0.026。
- 肿瘤分级G2对比G1:sHR=2.809,95%CI 1.171-6.743,p=0.021。
- 神经周围侵犯:sHR=2.715,95%CI 1.005-7.333,p=0.049。
- 影像侵袭指数:sHR=1.996,95%CI 1.008-3.951,p=0.047。
- 四项变量构成风险评分,可将患者分为不同风险组。
临床应用与阅片要点
- 术前CT影像征象可整合为影像侵袭指数,辅助术后复发风险评估。
- 报告G1/G2无功能胰腺神经内分泌肿瘤时,应关注肿瘤大小、分级及神经周围侵犯状态。
- 整合模型支持对患者进行风险分层,有助于制定个体化随访间隔。
局限性
- 原文指出需在更大的外部队列中进一步验证。
- 回顾性设计存在选择偏倚和信息偏倚的固有局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Although curative resection yields favorable outcomes for non-functional pancreatic neuroendocrine tumors (pNETs), postoperative recurrence remains a major concern. Existing studies have largely relied on postoperative pathological factors, while imaging characteristics have seldom been comprehensively integrated into recurrence prediction models. This study aimed to develop and validate an integrated model combining imaging and clinicopathological features to improve recurrence risk stratification.
METHODS: This multicenter retrospective cohort study included patients from three tertiary centers in China who underwent curative resection for non-functional, G1/G2 pNETs. Recurrence-related factors were identified using Fine-Gray competing risk regression. A weighted imaging invasiveness index was derived from six routine preoperative CT features, and an integrated prediction model combining imaging and clinicopathological variables was developed and validated.
RESULTS: The training and validation cohorts comprised 310 and 70 patients, respectively. Multivariable Fine-Gray model analysis identified four independent predictors of recurrence: tumor size (sHR = 1.111, 95% CI: 1.013-1.218, p = 0.026), tumor grade (G2 vs G1) (sHR = 2.809, 95% CI: 1.171-6.743, p = 0.021), perineural invasion (sHR = 2.715, 95% CI: 1.005-7.333, p = 0.049), and imaging invasiveness index (sHR = 1.996, 95% CI: 1.008-3.951, p = 0.047). Incorporating the imaging index improved predictive performance at 24 and 36 months in both cohorts, and a four-variable risk score stratified patients into distinct risk groups.
CONCLUSIONS: The integrated model combining the imaging invasiveness index with clinicopathological factors may improve recurrence prediction and support individualized risk stratification in patients with resected non-functional G1/G2 pNETs, although further validation in larger external cohorts is warranted.
引用
- Zhang, Yang, Tan, et al. Development and validation of an integrated imaging-pathology model for recurrence risk stratification in non-functional G1/G2 pancreatic neuroendocrine tumors: a multicenter study. Eur J Radiol. 2026. PMID: 42462489. doi:10.1016/j.ejrad.2026.113066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。